<DOC>
	<DOCNO>NCT01218672</DOCNO>
	<brief_summary>The study compare procedural post procedural outcome photoselective vaporization prostate ( PVP ) transurethral resection prostate ( TURP ) . The study require use CE mark GreenLight XPS™ Laser System ( GreenLight XPS ) CE mark monopolar bipolar loop TURP system treatment benign prostatic hyperplasia ( BPH ) . The purpose study demonstrate PVP inferior TURP .</brief_summary>
	<brief_title>A Study Comparing Photoselective Vaporization Prostate With GreenLight XPS™ Laser System Transurethral Resection Prostate Treatment Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Inclusion criterion : Subject provide informed consent agree attend study visit Subject diagnosis lower urinary tract symptom due benign prostatic enlargement cause bladder outlet obstruction Subject willing randomize Subject able complete selfadministered questionnaire Clinical investigator document subject 's medical record his/her judgment subject surgical candidate either PVP TURP procedure may randomize either arm Subject 40 80 year age Subject IPSS score great equal 12 measure baseline visit Subject medical record documentation maximum urinary flow rate ( Qmax ) less 15ml/s ( If uroflow test documentation available within 90 day prior inform consent date , sample great equal 150ml , Qmax le 15ml/s may use inclusion/exclusion criterion ) Subject medical record documentation prostate volume less equal 100g transrectal ultrasound ( TRUS ) ( If TRUS test documentation available le 180 day prior inform consent date prostate volume less equal 100g , may use inclusion/exclusion criterion ) Subject classified American Society Anesthesiologists ( ASA ) I , II III Subject serum creatinine within normal range laboratory study center ( documentation clinical insignificance subject 's medical record investigator outside normal range ) measure less equal 30 day prior date surgery . Exclusion criterion : Subject life expectancy le 2 year Subject currently enrol , plan enroll , concurrent drug device study unless preapproved sponsor Subject active infection ( eg , urinary tract infection prostatitis ) Subject diagnosis , receive treatment , chronic prostatitis chronic pelvic pain syndrome ( eg , nonbacterial chronic prostatitis ) Subject diagnose urethral stricture bladder neck contracture within 180 day prior inform consent date Subject diagnose 2 urethral stricture and/or bladder neck contracture within 5 year prior inform consent date Subject diagnosis lichen sclerosus Subject neurogenic bladder neurological disorder would impact bladder function ( eg , multiple sclerosis , Parkinson 's disease , spinal cord injury ) Subject diagnosis polyneuropathy ( eg , diabetic ) Subject history lower urinary tract surgery ( eg , TURP , laser , urinary diversion , artificial urinary sphincter , penile prosthesis ) Subject diagnosis stress urinary incontinence require treatment daily pad/device use Subject history intermittent self catheterization Subject catheterize PVR &gt; 400mls 14 day prior surgical procedure Subject current diagnosis bladder stone Subject diagnosis prostate cancer Subject history CIS , TaGII , TaGIII T1 stage bladder cancer Subject damage external urinary sphincter Subject medical contraindication undergo either TURP PVP surgery ( eg , infection , coagulopathy significant cardiac medical risk factor surgery ) Subject disorder coagulation cascade ( eg , hemophilia ) disorder affect platelet count function ( eg , Von Willebrand 's disease ) would put subject risk intraoperative postoperative bleeding Subject unable discontinue anticoagulant antiplatelet therapy preoperatively ( 35 day ) except low dose aspirin ( eg , less equal 100mg ) Subject acute myocardial infarction , open heart surgery cardiac arrest le 180 day prior date informed consent Subject immunocompromised ( eg , organ transplant , leukemia )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>BPH</keyword>
	<keyword>Benign Prostatic Hyperplasia</keyword>
</DOC>